Immunity to viruses in B cell-deficient mice: Influence of antibodies on virus persistence and on T cell memory

被引:89
作者
Brundler, MA
Aichele, P
Bachmann, M
Kitamura, D
Rajewsky, K
Zinkernagel, RM
机构
[1] UNIV ZURICH,INST EXPT IMMUNOL,DEPT PATHOL,CH-8091 ZURICH,SWITZERLAND
[2] SCI UNIV TOKYO,RES INST BIOL SCI,NODA,CHIBA 278,JAPAN
[3] UNIV COLOGNE,INST GENET,D-5000 COLOGNE,GERMANY
关键词
lymphocytic choriomeningitis virus; vesicular stomatitis virus; neutralizing antibodies; memory; B cell-deficient mice;
D O I
10.1002/eji.1830260943
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice rendered B cell deficient by targeted disruption of the immunoglobulin Cc chain gene (IgM-/- mice) were used to analyze the role of antibodies and B cells in viral infections; homozygous IgM-/- mice were bred in a way to avoid transmission of maternal antibodies. After infection with vesicular stomatitis virus (VSV), IgM-/- mice developed paralytic disease and subsequently died, whereas C57BL/6 control mice or IgM-/- mice passively protected with VSV-neutralizing antibodies survived. Furthermore, IgM-/- mice showed increased natural killer (NK) activity upon exposure to either lymphocytic choriomeningitis virus (LCMV) or to poly(I). poly(C), while NK activity in untreated IgM-/- mice was within normal ranges. Cytotoxic T cell responses were comparable in IgM-/- and control mice infected either with VSV or with vaccinia virus or with low doses of LCMV (10(2) infectious focus-forming units [ifu]). After intracerebral infection with LCMV-Armstrong, CD8(+) T cell-mediated lethal lymphocytic choriomeningitis developed independently of the presence of B cells and antibodies. After infection with high doses (2 x 10(6) - 5 x 10(6) ifu) of LCMV-WE or LCMV-Docile, IgM-/- mice exhibited a reduced capacity to control these primary infections and had elevated virus titers for prolonged times (> 60 days). Nevertheless, the cytotoxic T cell response against LCMV in the early phase of infection was comparable in IgM-/- and control mice, but disappeared in those IgM-/- mice which had a persistent viral infection. Cytotoxic T cell memory was apparently unimpaired in low-dose-primed IgM-/mice, which were able to control the primary virus infection; both IgM-/- and control mice cleared a high intravenous dose of virus within 2 days after challenge infection. This indicates that an efficient T cell memory against LCMV was established in the absence of B cells.
引用
收藏
页码:2257 / 2262
页数:6
相关论文
共 45 条
  • [1] CD8 T cell memory in B cell-deficient mice
    Asano, MS
    Ahmed, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) : 2165 - 2174
  • [2] MECHANISMS OF ANTIBODY-MEDIATED PROTECTION AGAINST LYMPHOCYTIC CHORIOMENINGITIS VIRUS-INFECTION - MOTHER-TO-BABY TRANSFER OF HUMORAL PROTECTION
    BALDRIDGE, JR
    BUCHMEIER, MJ
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (07) : 4252 - 4257
  • [3] ENHANCED ESTABLISHMENT OF A VIRUS CARRIER STATE IN ADULT CD4+ T-CELL-DEFICIENT MICE
    BATTEGAY, M
    MOSKOPHIDIS, D
    RAHEMTULLA, A
    HENGARTNER, H
    MAK, TW
    ZINKERNAGEL, RM
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4700 - 4704
  • [4] QUANTIFICATION OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS WITH AN IMMUNOLOGICAL FOCUS ASSAY IN 24-WELL OR 96-WELL PLATES
    BATTEGAY, M
    COOPER, S
    ALTHAGE, A
    BANZIGER, J
    HENGARTNER, H
    ZINKERNAGEL, RM
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1991, 33 (1-2) : 191 - 198
  • [5] BATTEGAY M, 1993, J IMMUNOL, V151, P5408
  • [6] CERNY A, 1985, EXP CELL BIOL, V53, P301
  • [7] IMMUNITY TO LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN B-CELL-DEPLETED MICE - EVIDENCE FOR B-CELL AND ANTIBODY-INDEPENDENT PROTECTION BY MEMORY T-CELLS
    CERNY, A
    HUEGIN, AW
    SUTTER, S
    BAZIN, H
    HENGARTNER, HH
    ZINKERNAGEL, RM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (08) : 913 - 917
  • [8] CLEARANCE OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN ANTIBODY-DEPRIVED AND B-CELL-DEPRIVED MICE
    CERNY, A
    SUTTER, S
    BAZIN, H
    HENGARTNER, H
    ZINKERNAGEL, RM
    [J]. JOURNAL OF VIROLOGY, 1988, 62 (05) : 1803 - 1807
  • [9] CHESNUT RW, 1981, J IMMUNOL, V126, P1075
  • [10] COLE GA, 1972, NATURE, V238, P335, DOI 10.1038/238335a0